FDA Adverse Event Injury Summary report: N

MOTO PARTIAL KNEE ANATOMICAL FEMORAL COMPONENT CEMENTED S3 RM

MDR report key: 16885914 · Received May 8, 2023

Report

Report Number
3005180920-2023-00334
Event Type
Injury
Date Received
May 8, 2023
Date of Event
April 12, 2023
Report Date
May 8, 2023
Manufacturer
MEDACTA INTERNATIONAL SA
Product Code
HSX
UDI-DI
07630030895586
PMA / PMN Number
K162084
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MO, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

BATCH REVIEW PERFORMED ON 19 APRIL 2023: LOT 2105455: (B)(6) ITEMS MANUFACTURED AND RELEASED ON 18-MAY-2021. EXPIRATION DATE: 2026-05-04. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, ALL ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. ADDITIONAL DEVICES INVOLVED: BATCH REVIEWS PERFORMED ON 19 APRIL 2023 MOTO PARTIAL KNEE 02.18.IF4.08.RM TIBIAL INSERT FIX S4 RM - 8MM (K162084) LOT 2103536: (B)(6) ITEMS MANUFACTURED AND RELEASED ON 05-MAY-2021. EXPIRATION DATE: 2026-04-22. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(6) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW. MOTO PARTIAL KNEE 02.18.TF4.RM TIBIAL TRAY FIX CEMENTED S4 RM (K162084) LOT 2103556: (B)(6) ITEMS MANUFACTURED AND RELEASED ON 27-MAY-2021. EXPIRATION DATE: 2026-05-11. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(6) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITHOUT ANY SIMILAR REPORTED EVENT DURING THE PERIOD OF REVIEW.

Description of Event or Problem · 0

AT ABOUT 1 YEAR 6 MONTHS AFTER THE PRIMARY, THE PATIENT CAME IN REPORTING PAIN AND THE CAUSE IS UNKNOWN. THE SURGEON REVISED THE PATIENT FROM MOTO TO SPHERE AND THE SURGERY WAS COMPLETED SUCCESSFULLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1955612 MOTO PARTIAL KNEE ANATOMICAL FEMORAL COMPONENT CEMENTED S3 RM KNEE CEMENTED FEMUR HSX MEDACTA INTERNATIONAL SA 02.18.003RM 2105455 07630030895586

Patients

Seq Age Sex Outcome Treatment
1 Male Required Intervention